IMB to investigate controversial pain killer

Claire O’Sullivan

IMB to investigate controversial pain killer
Tue, 01 Feb, 2005 - 00:00

The IMB said it had no immediate plans to withdraw Distalgesic, which is sold in Britain under the brand name Co-proxamol.

It was revealed yesterday the drug is to be taken off British pharmacy shelves over the next six to 12 months.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

ULSTER Spy 2 Man due in court over killing of informer Denis Donaldson
Certificate of loss for early miscarriages could be in place by next year, Oireachtas hears Certificate of loss for early miscarriages could be in place by next year, Oireachtas hears
Man filling up the gas tank with gasoline Inflation in Ireland rises to 3.6% as energy costs surge
CourtsHealthPlace: BritainPlace: IrelandPlace: EnglandPlace: WalesPerson: Claire O’SullivanPerson: David KellyPerson: President of thePerson: Karl HiltonPerson: HiltonOrganisation: IMBOrganisation: Irish Medicine BoardOrganisation: British Committee on Safety of MedicineOrganisation: Irish Medicines BoardOrganisation: MundipharmaOrganisation: Irish Pharmaceutical UnionOrganisation: IPU
<p>Arnold Schwarzenegger lifts his honorary doctorate presented to him by the Ulster University in Belfast. Picture: Liam McBurney/PA</p>

'Hasta La Vista Ulster': Arnold Schwarzenegger presented with honorary degree in Belfast

READ NOW

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited